搜档网
当前位置:搜档网 › Gut_microbiota__immunity__and_disease_a_complex_relationship.1

Gut_microbiota__immunity__and_disease_a_complex_relationship.1

Gut_microbiota__immunity__and_disease_a_complex_relationship.1
Gut_microbiota__immunity__and_disease_a_complex_relationship.1

REVIEW ARTICLE published:05September2011 doi:10.3389/fmicb.2011

.00180 Gut microbiota,immunity,and disease:a complex relationship

Michele M.Kosiewicz,Arin L.Zirnheld and Pascale Alard*

Department of Microbiology and Immunology,Health Sciences Center,University of Louisville,Louisville,KY,USA

Edited by:

Alain Stintzi,Ottawa Institute of Systems Biology,Canada

Reviewed by:

Deborah Threadgill,North Carolina State University,USA

Peter J.Turnbaugh,Harvard University,USA

*Correspondence:

Pascale Alard,Department of Microbiology and Immunology, University of Louisville,319Abraham Flexner way,Louisville,KY40202, USA.

e-mail:p0alar01@https://www.sodocs.net/doc/0a15105227.html, Our immune system has evolved to recognize and eradicate pathogenic microbes.How-ever,we have a symbiotic relationship with multiple species of bacteria that occupy the gut and comprise the natural commensal?ora or microbiota.The microbiota is critically important for the breakdown of nutrients,and also assists in preventing colonization by potentially pathogenic bacteria.In addition,the gut commensal bacteria appear to be criti-cal for the development of an optimally functioning immune system.Various studies have shown that individual species of the microbiota can induce very different types of immune cells(e.g.,Th17cells,Foxp3+regulatoryT cells)and responses,suggesting that the compo-sition of the microbiota can have an important in?uence on the immune response.Although the microbiota resides in the gut,it appears to have a signi?cant impact on the systemic immune response.Indeed,speci?c gut commensal bacteria have been shown to affect disease development in organs other than the gut,and depending on the species,have been found to have a wide range of effects on diseases from induction and exacerbation to inhibition and protection.In this review,we will focus on the role that the gut microbiota plays in the development and progression of in?ammatory/autoimmune disease,and we will also touch upon its role in allergy and cancer.

Keywords:commensal bacteria,microbiota,autoimmunity,allergy,cancer,T reg,Th17,probiotics

INTERACTION BETWEEN THE GUT MICROBIOTA AND THE IMMUNE SYSTEM

The trillions of commensal microorganisms that constitute the intestinal microbiota are primarily composed of?ve bacterial phyla,Firmicutes,Bacteroidetes,Actinobacteria,Proteobacteria,and Fusobacteria.Bacteroidetes and Firmicutes predominate and rep-resent~90%of the total gut microbiota(i.e.,25and65%,respec-tively;Rajilic-Stojanovic et al.,2007).However,these proportions can vary greatly between individuals and even within single indi-vidual over time.Although commensal bacteria inhabit the entire gut,greater numbers reside in the distal part of the small intestine and in the large intestine or colon.Acquisition of the intesti-nal microbiota occurs in the?rst year of life and is in?uenced by the maternal bacteria obtained during vaginal delivery(Ben-net and Nord,1987;Mandar and Mikelsaar,1996;Penders et al., 2006),versus Cesarean section(Dominguez-Bello et al.,2010),and breastfeeding(Yoshioka et al.,1983;Balmer and Wharton,1989; Harmsen et al.,2000;Hopkins et al.,2005).Early in life the major shifts in the gut microbiota can be caused by antibiotics,dietary changes,etc.(Koenig et al.,2011)as opposed to a purely stochastic model(Palmer et al.,2007).However,there is a lack of large-scale studies of temporal variation in adults.

The gut microbiota plays a critical role in the breakdown of indigestible complex plant polysaccharides,and provides an important layer of defense against invasion by pathogenic microorganisms.It is also required for proper development of the immune system,as indicated by the fact that germ-free(GF)mice have poorly developed lymphoid tissues.GF mice have spleens with few germinal centers and poorly formed T and B cell zones,hypoplastic Peyer’s patches,lower numbers of lamina propria CD4+cells and IgA-producing plasma cells(Macpherson and Har-ris,2004),and aberrant development and maturation of isolated lymphoid follicles(Bouskra et al.,2008).The lymphoid organs of GF mice exhibit aberrant development of T and B cell subsets,and more speci?cally,contain CD4+T cells that are skewed toward an T helper2(Th2)phenotype and produce little,if any,IFNγ(Mazmanian et al.,2005),and have fewer and smaller germinal centers(Bauer et al.,1963).There is also evidence that the micro-biota plays a key role in the induction of IgA(Klaasen et al.,1993b; Talham et al.,1999)and maintenance of homeostasis of various T cell populations in the gut,including regulatory T cells(Tregs), and T helper1(Th1)and17(Th17)cells(Gaboriau-Routhiau et al.,2009).

The commensal bacteria that reside in the gut are diverse,and individual species appear,in some cases,to have distinct and opposing roles.Some commensal bacteria appear to drive Treg development preferentially,while others promote Th17develop-ment.In a comparative analysis of terminal ileal tissue from mice maintained in conventional(CV)versus GF housing,tissue from CV mice exhibited5-to10-fold higher IL-10and Foxp3mRNA expression compared to GF mice,suggesting that the microbiota can drive Foxp3+Treg induction and/or expansion in the intes-tine(Gaboriau-Routhiau et al.,2009).Furthermore,in the Peyer’s patches and mesenteric lymph nodes(LN)of naive GF mice,Tregs were at a decreased frequency,were less effective at suppressing responder cell proliferation in vitro,and produced lower levels of IL-10and TGFβthan naive mice housed under speci?c pathogen-free(SPF)conditions(Ishikawa et al.,2008).The colonization of

GF mice with Bacteroides fragilis increases the suppressive capac-ity of Tregs and induces anti-in?ammatory cytokine production by Foxp3+T cells in the gut(Mazmanian et al.,2008).Similarly, colonization of GF mice with a cocktail of Clostridium strains increased dramatically the frequency of IL-10-producing Helios?Tregs(induced Tregs)in the colonic lamina propria(Atarashi et al.,2011).Numerous studies have also found that Tregs are induced following gavage with gut commensal bacteria of either the Lactobacillus or Bi?dobacterium genus(Di Giacinto et al., 2005;O’Mahony et al.,2008;Karimi et al.,2009;Livingston et al., 2010;Zhang et al.,2010).In contrast,Th17cell responses appear to be induced by a restricted number of microbial species,e.g., segmented?lamentous bacteria(SFB).Candidatus arthromitus, commonly called SFB,are Gram-positive bacteria of the Firmi-cutes phylum and most closely related to the Clostridium genus (Snel et al.,1995).These bacteria colonize the small intestine and have been shown to stimulate the production of secretory IgA(Klaasen et al.,1993b;Talham et al.,1999)and to activate CD8αβ+TCRαβ+intraepithelial cells in the small intestine(Ume-saki et al.,1995).The SFB are thought to play a key role in the maturation of the adaptive mucosal immune response in the gut. Indeed,SFB colonization of GF mice has been shown to induce differentiation of primarily IL-17+T cells(Ivanov et al.,2008, 2009;Gaboriau-Routhiau et al.,2009)and to a far lesser extent, IFNγ+Th1and IL-10+Treg cells(Gaboriau-Routhiau et al.,2009). These data indicate that SFB can promote the development of intestinal Th17cells,a population of T cells that is not only impor-tant for?ghting bacterial infection,but is also involved in the pathogenesis of a number of in?ammatory and autoimmune dis-eases.A microbiota favoring SFB could,therefore,have an impact on the immune response,and consequently,on the development of Th17-mediated in?ammatory/autoimmune diseases in the gut and at distant sites in predisposed individuals.The speci?c mech-anisms that lead to the preferential induction of Tregs versus Th17 cells by various commensal bacteria are currently unknown.How-ever,DNA derived from commensal bacteria has been shown to play a major role in intestinal homeostasis through toll-like receptor9(TLR9)engagement,and appears to be involved in con-trolling the balance between Tregs and effector cells.Indeed,TLR9 de?cient(TLR9?/?)mice exhibit increases in intestinal Foxp3+ Tregs,and decreases in IL-17and IFN-γproduction by compar-ison to wild-type mice(Hall et al.,2008).One could speculate that speci?c commensal species may differentially modulate the T effector/Treg cell balance via this mechanism,since the ability of gut commensal bacteria to stimulate TLR9varies and depends on the frequency of CG dinucleotides(Dalpke et al.,2006).

The composition of the microbiota can be in?uenced by vari-ous factors,including diet and exposure to antibiotics.Analysis of the fecal microbiota of humans and59other mammalian species has shown that the gut microbiota of humans living a mod-ern lifestyle is typical of omnivorous primates(Ley et al.,2008). Moreover,feeding GF mice colonized with human fecal micro-bial communities a high-fat,high sugar“Western”diet instead of a low-fat,plant polysaccharide-rich diet signi?cantly altered the microbiota composition,resulting in an increase in Firmicutes and decrease in Bacteroidetes(Turnbaugh et al.,2009).In con-trast,a diet very high in?ber has been associated with increases in Bacteroidetes and a much lower abundance of Firmicutes in humans(De Filippo et al.,2010),although other factors may confound these comparisons.Interestingly,?uctuations in the pro-portions of these types of commensal bacteria have been found in patients and animals with in?ammatory/autoimmune diseases (see below).In addition,antibiotic treatment is usually followed by a decrease in the diversity of the microbiota.Although the composition of the microbiota is similar in the days or weeks following the termination of treatment,some bacterial members are lost from the community inde?nitely(Jernberg et al.,2007; Jakobsson et al.,2010).Furthermore,different types of antibiotics differentially affect bacteria and,consequently,immune cell devel-opment.Antibiotic treatment(ampicillin,gentamicin,metron-idazole,neomycin,and vancomycin)that reduced bacteria from the Firmicutes phylum while increasing the proportion of bacteria from the Bacteroidetes,phylum was associated with a reduction in mucosal CD4+T cells expressing IFNγand IL-17(Hill et al., 2010).Similarly,vancomycin or ampicillin treatment,both of which inhibit Gram-positive bacteria,dramatically decreased the numbers of Th17cells in the lamina propria.In contrast,metron-idazole or neomycin,which target anaerobes and Gram-negative bacteria,had little effect on the Th17cell population(Ivanov et al., 2008).Because the microbiota profoundly affects immune system development and maturation,it is not surprising that modula-tion of the balance between the various commensal bacteria can in?uence in?ammatory/autoimmune disease development and/or progression.

INVOLVEMENT OF COMMENSAL BACTERIA IN PROTECTION AGAINST AUTOIMMUNITY

The less than100%concordance rate for autoimmune diseases in monozygotic twins(e.g.,<40%for type1diabetes;Hyttinen et al.,2003),suggests that environmental factors can have a strong in?uence on in?ammatory/autoimmune disease development. The composition of the microbial community that comprises the microbiota varies between individuals including monozygotic twins.Because the gut commensal bacteria in?uences the devel-opment of the immune system,the microbiota could be one of the environmental factors that affects in?ammatory/autoimmune disease development in genetically susceptible individuals,i.e.,dif-ferences in its composition could contribute to the lower than expected concordance rate in monozygotic twins.The composi-tion of the gut microbiota may,therefore,either confer protection or trigger disease in genetically susceptible individuals.

Considerable evidence indicates that the composition of the microbiota can in?uence the development of intestinal in?amma-tion.Some commensal bacteria may induce intestinal in?amma-tion while others control it.The commensals capable of controlling in?ammation in the gut mediate their effect either by balanc-ing the immune response in favor of regulation or by controlling bacteria that may directly mediate intestinal in?ammation.With regard to balancing the immune response,commensal bacteria from the Bacteroidetes and Firmicutes phyla appear to induce Tregs that can control Th17cells that are responsible for intesti-nal in?ammation.In a recent report,colonization of GF mice with the human commensal,B.fragilis,was shown to induce IL-10production and Foxp3expression,decrease Th17cells and

prevent colitis development.Furthermore,injection of polysac-charide A(PSA)isolated from B.fragilis was found to recapitulate the effects of colonization with B.fragilis(Mazmanian et al., 2008;Round and Mazmanian,2009),with PSA-induced signaling through TLR2expressed by Tregs promoting tolerance(Round et al.,2011).In addition,mice orally inoculated with murine Clostridium species belonging to clusters IV and XIVa(Firmicutes phylum)were resistant to colitis development and exhibited an increase in the frequency of colonic Tregs(Atarashi et al.,2011). Various human Lactobacillus strains(of the Firmicutes phylum) have also been shown to be protective in several animal mod-els of colitis,including the TNBS-induced and IL-10de?cient mouse models of colitis,and were found to mediate their effect via induction of Tregs(Di Giacinto et al.,2005;O’Mahony et al., 2008;Livingston et al.,2010).Commensal bacteria can also affect other potentially pathogenic bacteria;for example,commensal bacteria from the Actinobacteria phylum appear to control the levels of other commensal bacteria that cause intestinal in?am-mation.Administration of Bi?dobacterium animalis https://www.sodocs.net/doc/0a15105227.html,ctis (Actinobacteria phylum)reduced intestinal in?ammation in the T-bet?/?Rag2?/?model of colitis.This was associated with a con-comitant reduction in Enterobacteriaceae levels,the commensal bacteria shown to initiate intestinal in?ammation in this colitis model.Moreover,the authors reported that the fecal levels of Bi?dobacterium in untreated T-bet?/?Rag2?/?mice were lower compared to control mice,and found that the Bi?dobacterium fecal levels were inversely related to the colitis score(Veiga et al.,2010).Taken together,these studies demonstrate that sev-eral different species of commensal bacteria can control in?am-mation in the gut via different mechanisms,e.g.,by directly regulating the immune response or by affecting the composi-tion of the microbiota and reducing other disease-mediating commensals.

Commensal bacteria can also have a protective effect at sites dis-tant from the gut.The results of one recent study suggest that the microbiota plays an important role in type1diabetes in genetically susceptible mice.Type1diabetes-susceptible NOD mice that were crossed with MyD88?/?mice(NODMyD88?/?)were found to be protected from type1diabetes.This protection appeared to involve changes in the composition of the microbiota,since protection was abrogated when NODMyD88?/?mice were treated with antibi-otics or derived and maintained under GF conditions.A com-parison of the gut microbiota between NODMyD88suf?cient and NODMyD88?/?mice con?rmed that there were differences in the microbiota composition which could account for the differences in disease susceptibility.The NODMyD88?/?mice had a lower Fir-micutes/Bacteroidetes ratio than the NODMyD88suf?cient mice, and an enrichment in cecal Lactobacillacae,Rikenellaceae,and Porphyromonadaceae.Finally,wild-type NOD mice that were colo-nized at birth with microbiota from NODMyD88?/?mice exhib-ited signi?cantly reduced islet in?ltration compared to untreated NOD mice(Wen et al.,2008),i.e.,the microbiota from the NODMyD88?/?mice conferred some protection from diabetes to wild-type NOD mice.Moreover,a recent publication has reported that female NOD mice colonized with SFB exhibited a large Th17 population in the lamina propria of the small intestine and were protected from developing type1diabetes(Kriegel et al.,2011).These?ndings corroborate studies showing that Th17cells do not directly mediate type1diabetes in NOD mice(Bending et al.,2009; Martin-Orozco et al.,2009),and in fact,appear to act as regulatory cells that protect against disease development(Han et al.,2010; Nikoopour et al.,2010).Interestingly,a recent study has shown that Th17cell pathogenicity can be controlled in the small intestine, where pro-in?ammatory Th17cells can acquire a regulatory phe-notype(rTh17)that includes in vivo immunosuppressive proper-ties(Esplugues et al.,2011).Taken together,these data suggest that gut microbiota has a signi?cant,if complex,in?uence on the devel-opment of in?ammatory/autoimmune diseases.Another study has found that the microbiota plays a protective role in a model of collagen-induced arthritis.The study found that rats maintained in a GF environment developed more severe rheumatoid arthritis (RA)than rats maintained in a conventional environment,sug-gesting that the microbiota had a suppressive effect on RA develop-ment(Breban et al.,1993).Lastly,a series of studies has shown that the microbiota can protect against central nervous system(CNS) disease.Oral administration of antibiotic,leading to a reduction in bacteria from the Firmicutes phylum,but a relative increase in bacteria from the Bacteroidetes phylum,impaired the development of myelin oligodendrocyte glycoprotein(MOG)or proteolipid protein-induced experimental autoimmune encephalitis(EAE)in mice.In this study,protection was associated with diminished pro-in?ammatory responses,higher numbers of Tregs in mesenteric LN and potent IL-10-producing Foxp3+Tregs that were present in the LN(Ochoa-Reparaz et al.,2009,2010).Moreover,oral administration of PSA isolated from B.fragilis(of the Bacteroidetes phylum)was able to prevent EAE development via enhancement of CD103+DC that converted na?ve T cells into IL-10-producing Foxp3+Tregs,suggesting that antibiotic-mediated protection is mediated the increase in Bacteroidetes(Ochoa-Reparaz et al.,2009, 2010).Finally,oral administration of probiotics,including the Lac-tobacillus and Bi?dobacterium species,has been shown to protect against development of various autoimmune diseases such as type 1diabetes(Matsuzaki et al.,1997;Calcinaro et al.,2005),exper-imental autoimmune encephalomyelitis(Lavasani et al.,2010), experimental RA(Kato et al.,1998;Baharav et al.,2004;So et al., 2008),and systemic lupus erythematosus(personal observation; Alard et al.,2009),via induction of IL-10-producing Tregs and attenuation of Th1and Th17cytokines.It is not clear whether the Tregs are induced upon direct interaction with the probi-otics and/or via stimulation with tolerogenic antigen presenting cells that have been induced by the probiotics.We have,however, shown recently that dendritic cells cultured with Lactobacillus casei shift their cytokine pro?le in favor of IL-10,and are able to pre-vent type1diabetes development upon injection into NOD mice. Since a single injection of L.casei-treated DC is suf?cient to medi-ate long-term protection,the mechanism in this case most likely involves induction of regulatory cells(Manirarora et al.,2011). Altogether,these data emphasize the importance of a balanced gut microbiota that can induce a protective immune response capable of suppressing in?ammation in organs distant from the gut,via induction of tolerogenic DC and Tregs.How these cells traf?c from the gut to the distal lymph nodes and possibly to the peripheral tissue(CNS,joint,pancreas)is currently unknown and remains to be determined.

Studies have indicated that the composition of the microbiota can have a signi?cant effect on the development of in?amma-tory/autoimmune disease in humans.The composition of the gut microbiota differs greatly in subsets of patients with in?amma-tory bowel disease(IBD),including Crohn’s disease and ulcerative colitis,compared to non-IBD individuals.The microbiota of IBD patients is characterized by depletion of Bacteroidetes and Firmi-cutes(Frank et al.,2007).More speci?cally,recurrence of Crohn’s disease was associated with decreases in the relative proportion of Faecalibacterium prausnitzii,a bacterium belonging to Clostridium cluster IV,in these patients(Sokol et al.,2009).In animal studies, F.prausnitzii has been shown to have anti-in?ammatory effects, and oral administration of F.prausnitzii has been found to reduce the severity of TNBS-induced colitis(Sokol et al.,2008).These data suggest that restoration of the microbial balance in IBD patients may be a good strategy to treat this disease,and in fact,administra-tion of VSL#3,a cocktail of several Lactobacillus species(L.Casei, Lactobacillus plantarum,Lactobacillus acidophilus,and Lactobacil-lus delbrueckii),Bi?dobacterium species(Bi?dobacterium longum, Bi?dobacterium breve,and Bi?dobacterium infantis)and a Strepto-coccus salivarius subsp.,Thermophilus,has been shown to decrease ulcerative colitis in patients with mild to moderately active ulcera-tive colitis(Sood et al.,2009;Tursi et al.,2010).Studies in patients with early RA have also found that Bi?dobacteria and B.fragilis in the gut are decreased(Vaahtovuo et al.,2008),suggesting that alteration in the abundance of these two commensal species may in?uence the pathogenesis of RA.However,in patients with estab-lished disease,the possibility that an alteration in the composition of the microbiota may be a consequence rather than a cause of the disease cannot be ruled out.

In conclusion,commensal bacteria belonging to the Bi?dobac-terium,Bacteroides,Clostridium,and Lactobacillus genera are asso-ciated with in?ammatory/autoimmune disease protection.There-fore,establishing a balanced microbiota in favor of these protective commensal bacteria may be a good strategy for the preven-tion and/or treatment of in?ammatory/autoimmune diseases in autoimmune-prone individuals.

INVOLVEMENT OF COMMENSAL BACTERIA IN TRIGGERING INFLAMMATORY/AUTOIMMUNE DISEASE

Microbial pathogens have long been implicated in the etiology of a variety of autoimmune/in?ammatory diseases,including IBD (Sanderson and Hermon-Taylor,1992;Chen et al.,2000),RA (Toivanen,2003),experimental autoimmune encephalomyelitis (Cermelli and Jacobson,2000;Buljevac et al.,2005;Gilden,2005; Farrell et al.,2009),type1diabetes(Filippi and von Herrath,2005), and systemic lupus erythematosus(Cavallo and Granholm,1990; Zandman-Goddard and Shoenfeld,2005;Poole et al.,2006).How-ever,a growing body of evidence suggests that speci?c commensal bacteria may also negatively impact in?ammatory and autoim-mune diseases in genetically susceptible individuals.Interestingly, rendering mice germ-free(GF)can dramatically alter in?amma-tory/autoimmune disease incidence and severity,and/or the kinet-ics of disease onset and progression in animal models of disease. This is not surprising since we know that commensal bacteria play an important role in shaping the host systemic immune response. However,the mechanisms underlying the relationship between commensal microorganisms and the induction/exacerbation of autoimmune/in?ammatory diseases are poorly understood.Fur-thermore,it is unclear how individual microbial species compris-ing the microbiota contribute to the effects on these diseases. Recent studies focusing on the relationship between the micro-biota and induction of autoimmunity have begun to shed some light on these issues.

Most mouse models of colitis are antibiotic-responsive,and patients with IBD often bene?t from treatment with antibi-otics,suggesting that bacteria play a role in disease pathogenesis. The general consensus is that IBD may be driven by aberrant pro-in?ammatory host responses to the commensal microbiota (Packey and Sartor,2008).A recent study has found that the micro-biota can induce in?ammation in models of colitis by activating T cells via both innate and adaptive immune mechanisms(Feng et al.,2010).In that study,homeostatic proliferation of transferred T cells was inhibited in GF RAG?/?mice,but restored after recon-stitution with Altered Schaedler’s Flora(a standardized cocktail of mouse microbiota),indicating that T cells require the presence of the microbiota to proliferate.Moreover,microbiota-induced production of IL-6by DC was required to reach the threshold number of IFNγand IL-17-producing microbiota-speci?c T cells (i.e.,induction of T cell proliferation)that was needed to induce colitis(Feng et al.,2010).In other studies,a number of bac-terial species isolated from the intestines of IBD patients have been shown to be capable of inducing intestinal in?ammation in rodents,including Helicobacter hepaticus,enterotoxigenic B.frag-ilis,and Bacteroides vulgatus.H.hepaticus infection is associated with the spontaneous development of colitis in some types of immunode?cient,but not immunocompetent mice(Ward et al., 1996).Furthermore,colonization with enterotoxigenic strains,but not non-toxigenic strains,of B.fragilis have been shown to induce colitis.Enterotoxigenic B.fragilis of human origin mediates col-itis in multiple intestinal neoplasia(Min)transgenic mice in a Th17cell-dependent manner(Wu et al.,2009).Similarly,entero-toxigenic B.fragilis of piglet origin has been shown to enhance DSS-induced colitis in mice(Rabizadeh et al.,2007),and the B. fragilis toxin appears to be essential for disease pathogenesis(Rhee et al.,2009).In an older study,colitis severity was found to be increased in a carrageenan-based model of colitis in guinea pigs after oral administration of B.vulgatus isolated from IBD patients, but not healthy individuals.This disease exacerbation could be transferred to recipients via spleen cells(Onderdonk et al.,1984), suggesting that bacteria isolated from IBD patients were induc-ing a cell-mediated(most likely T cell)immune response capable of enhancing in?ammation.Interestingly,another study has found that a single species of commensal bacteria,?lamentous segmented bacteria(SFB),can induce intestinal in?ammation in the presence of a limited microbiota(Stepankova et al.,2007).In this study, GF SCID mice were colonized with individual or combinations of strains of anaerobic and aerobic bacteria and SFB,including Enterococcus faecalis,SFB,Fusobacterium mortiferum,Bacteroides distasonis,F.mortiferum+SFB,B.distasonis+SFB,and a SPF bac-terial cocktail with limited diversity(SPF cocktail)±https://www.sodocs.net/doc/0a15105227.html,ing the CD45high transfer model of intestinal in?ammation,the study found that only the mice colonized with the SPF cocktail+SFB developed clinical and histological signs of intestinal in?ammation

following transfer of CD45RB high cells(Stepankova et al.,2007). These data indicate that,unlike SFB,most gut bacteria cannot or do not trigger intestinal in?ammation in the presence of a limited microbiota,such as the typical SPF bacteria.

The involvement of SFB in in?ammatory disease pathogenesis is not limited to the intestine.Two recent studies have shown that SFB may also be involved in development of experimental autoim-mune encephalomyelitis(EAE)(Lee et al.,2011)and rheumatoid arthritis(RA)(Wu et al.,2010).In the?rst study,the authors found that GF mice exhibited decreased severity of MOG-induced EAE compared to mice raised under SPF conditions.The reduced severity was associated with reduced IL-17A and IFNγproduction and RORγt transcripts,but elevated levels of CD4+CD25+Foxp3+ cells.Interestingly,whereas transfer of CD4+T cells from MOG-immunized GF mice into RAG?/?GF mice only induced very mild EAE,transfer of CD4+T cells from MOG-immunized stan-dard pathogen free(SPF)mice induced severe disease,suggesting that the gut microbiota plays a role in activating T cells capable of inducing EAE.Finally,intestinal colonization of GF mice with SFB alone restored susceptibility to severe EAE induction,and cor-related with elevated IL-17and IFNγexpression in T cells in the spinal cord and small intestine lamina propria as well as a reduc-tion of Foxp3+T cell levels.This study demonstrates that intestinal colonization with SFB can induce Th17cells that attack the cen-tral nervous system(CNS)(Lee et al.,2011).In the second study, arthritis-prone K/BxN mice raised under GF conditions exhib-ited attenuated RA that was associated with a reduction in serum autoantibody titers,splenic autoantibody-secreting cells,germinal centers,and IL-17.Interleukin-17was found to be critical for the pathogenesis of the disease in these mice,as treatment with anti-IL-17antibodies abrogated RA development in mice raised under SPF conditions.Interestingly,colonization of GF K/BxN mice with a single bacterial species,SFB,resulted in the rapid development of arthritis,which correlated with restoration of IL-17-producing T cells in the lamina propria.These cells could in turn migrate to the spleen where they provided help for germinal center forma-tion and antibody production(Wu et al.,2010).Therefore,SFB, a bacterium known to induce IL-17production(Ivanov et al., 2009),is capable of triggering RA in arthritis-prone K/BxN mice via activation of Th17cells(Wu et al.,2010).Colitis,EAE,and RA are all mediated by IL-17-producing cells,and it is perhaps not surprising that a commensal bacteria that induces Th17cells may be involved in the etiology of these diseases.However,it is surprising that a commensal gut bacteria(such as SFB)can play a role in the development of autoimmune disease at a distant site, i.e.,CNS(Lee et al.,2011)or joints(Wu et al.,2010).In fact,evi-dence of SFB-induced Th17cells could be found not only in the intestine,but also in the spinal chord and spleen,demonstrating that a single intestinal commensal bacterial species is capable of priming immune responses that are extra-intestinal and extend to peripheral lymphoid organs and tissues.However,the role that the intestinal SFB-induced Th17cells play at the disease sites,i.e.,in the spinal chord or the joints,remains to be determined.Several stud-ies have shown that the presence of IL-17in the joints enhanced disease(Lubberts et al.,2004;Jacobs et al.,2009),suggesting that Th17cells could amplify the in?ammatory process in the joints. Indeed,IL-17receptor is expressed by a wide range of synovial cells (Yao et al.,1995;Silva et al.,2003),and IL-17drives these cells to produce pro-in?ammatory mediators such as cytokines(GM-CSF)and chemokines(CXCL2,CXCL8),and induces recruitment of neutrophils(Laan et al.,1999,2003).Moreover,one could spec-ulate that Th17cells may also participate in the in?ammatory process by producing other cytokines capable of promoting the in?ammatory response.For instance,IL-23and GM-CSF have been shown very recently to play a crucial role in EAE induc-tion.Interleukin-23appears to induce Th17or RORγt+T cells to produce GM-CSF that is required for disease induction;this was demonstrated in experiments showing that GM-CSF-producing IL-17-de?cient T cells,but not GM-CSF-de?cient Th17cells,were able to induce EAE(Codarri et al.,2011;El-Behi et al.,2011). Furthermore,GM-CSF seems to target the myeloid cells that are responsible for sustaining in?ammation in the CNS(El-Behi et al., 2011).Depending on the type of autoimmune diseases or the site of in?ammation,SFB-induced Th17cells may therefore pro-mote/exacerbate in?ammation in tissue through the production of GM-CSF and/or IL-17.

Understanding the role that commensal bacteria play in dis-ease development in humans has been challenging.Studies about the composition of the gut microbiota in patients have identi-?ed bacteria with the potential to cause disease.Nonetheless,it is also possible that these microorganisms colonize the gut after disease is established and are not involved in the development of the disease.There is,however,a general consensus that IBD arises from an abnormal immune response to bacterial com-ponents of the intestinal microbiota(Packey and Sartor,2008). Indeed,it has been reported that a subset of people with Crohn’s disease harbor a strain of adherent–invasive Escherichia coli in their small intestine that is potentially pro-in?ammatory(Pine-ton de Chambrun et al.,2008).In addition,RA patients treated with antibiotics such as minocycline exhibit signi?cant disease improvement(Stone et al.,2003),suggesting that the commen-sal bacteria contributes,at some level,to disease development. Although it has been shown that humans can be colonized with SFB(Klaasen et al.,1993a),there is little evidence yet for involve-ment of SFB in in?ammatory/autoimmune diseases in humans. It would be of great interest to determine whether SFB is more prominent in the microbiota of patients exhibiting certain types of autoimmune diseases,i.e.,Th17-mediated.Moreover,multiple issues remain to be addressed concerning the involvement of SFB in autoimmune diseases,including identifying the molecules that mediate Th17cell induction as well as determining whether other Th17-mediated autoimmune diseases can be triggered by SFB. ROLE OF THE MICROBIOTA IN ALLERGIC DISEASES

In addition to in?ammatory and autoimmune diseases,there are other chronic diseases that may be impacted by the gut micro-bial community.In particular,allergic disease development has been associated with alterations in the intestinal microbiota.The incidence of allergic diseases has increased over the past40years in industrialized countries including the United States,Canada, United Kingdom,Ireland,New Zealand,and Australia,but not in developing countries.These data suggest that environmental changes are a major factor in the development of allergic dis-eases(Asher,1998;Mannino et al.,1998;Beasley et al.,2000).

The“hygiene hypothesis”suggests that the increase in the preva-lence of allergic diseases observed in developed countries could be due to decreased early exposure to infectious agents that may alter the immune response and,in particular,the immunoregula-tory compartment(Okada et al.,2010).However,the“micro?ora hypothesis”has been put forth as an alternative explanation and is based on changes in the intestinal microbiota that are due to antibiotic use and dietary differences(Noverr and Huffnagle, 2005).In either case,the regulatory mechanisms that normally control the Th2responses generally associated with allergic dis-eases and asthma would not develop properly.Indeed,treatment of normal3-week-old mice with the broad-spectrum antibiotic, kanamycin,results in the elimination of all Gram-negative bacte-ria in the stool,and a subsequent shift to a Th2response(Oyama et al.,2001),suggesting that intestinal bacteria are involved in controlling the Th2response.This was further supported in a study showing that treatment of mice with antibiotics combined with oral administration of the commensal fungus,Candida albi-cans,triggers pulmonary allergic responses(Noverr et al.,2004). Taken together,these studies suggest that the microbiota plays an important role in controlling allergic diseases.

Several studies have reported differences in the composition of the microbiota of infants who develop allergic diseases.Infants with food allergies were found to exhibit an imbalance between “bene?cial”and potentially harmful bacteria,i.e.,Lactobacilli and Bi?dobacteria species were lower while coliforms and Staphylococ-cus aureus were higher(Bjorksten et al.,1999).Decreased levels of Bi?dobacteria were also observed in infants with atopic eczema (Kirjavainen et al.,2001).Moreover,Bi?dobacteria and Entero-coccus were decreased while Clostridium was increased,resulting in a reduced ratio of Bi?dobacteria to Clostridia in infants that developed atopic dermatitis(Bjorksten et al.,2001).These data suggest that speci?c species of intestinal commensal bacteria can play either a pathogenic or protective role in allergies that occur in the gut or at sites distant from the gut,such as lung and skin.

Prophylactic approaches based on the administration of probi-otics to newborns at high risk for allergies have proven successful. The World Health Organization has de?ned probiotics as“live microorganisms which when administered in adequate amounts confer a health bene?t on the host”FAO/WHO(2002).Admin-istration of L.casei GG to the mothers before and after(via breastfeeding)delivery prevents atopic eczema,as well as other atopic diseases that develop later,in children at risk(Kalliomaki et al.,2001,2003).Protection from allergic diseases provided by oral administration of non-pathogenic E.coli in early life was shown to extend to adult life(Lodinova-Zadnikova et al.,2003). Finally,a number of studies have been performed using probiotics to treat pre-existing atopic disease in infants.These studies found that administration of Lactobacilli was able to decrease the severity of various allergic diseases,including atopic eczema,atopic der-matitis,and food allergy in these children(Majamaa and Isolauri, 1997;Kirjavainen et al.,1999;Rosenfeldt et al.,2003;Viljanen et al.,2005).There is no evidence to date indicating that probiotic therapies have a bene?cial effect on the incidence or severity of asthma in children at high risk(Vliagoftis et al.,2008).However, studies using animal models have found that oral administration of certain Lactobacilli and Bi?dobacterium species were able to modulate allergic responses in the respiratory tract apparently via induction of regulatory T cells,suggesting that it may be possible to treat asthma using an optimal combination of probiotics(Feleszko et al.,2007;Forsythe et al.,2007;Karimi et al.,2009;Lyons et al., 2010).

As described above for autoimmune diseases,microbiota that favor certain species of commensal bacteria appears to also predis-pose or protect susceptible individuals to allergy development at various extra-intestinal sites,including lung and skin.The mecha-nisms by which intestinal immune responses affect in?ammatory responses at distant sites are still unknown and remain to be established.

ROLE OF THE MICROBIOTA IN CANCER

The intestinal microbiota does not only in?uence autoimmune and allergic diseases,but has also been implicated in the devel-opment of cancer,especially colon cancer.Colorectal cancer is highly prevalent in the United States,with an estimated1in 20men and women receiving a diagnosis of colon or rectum cancer sometime during their lifetime(National Cancer Insti-tute Website:https://www.sodocs.net/doc/0a15105227.html,/statfacts/html/colorect.html). Similarly,colorectal cancer is the second and third most common cancer in women and men,respectively,in European Union coun-tries(Ferlay et al.,2007).This is an important heath problem in developed countries,where the primary risk factor is diet in up to 80%of all colorectal cancers(Bingham,2000).

Interestingly,accumulating evidence in the last3years has underscored the importance of the intestinal microbiota in the development of colorectal cancer(Bingham,2000;Davis and Mil-ner,2009;O’Keefe et al.,2009;Uronis et al.,2009).In fact,diet and the composition of the microbiota strongly correlate with the risk of developing colorectal cancer in certain groups of individu-als(Bingham,2000;Davis and Milner,2009;O’Keefe et al.,2009). One mechanism by which commensal bacteria contribute to the initiation of colorectal cancer involves the induction of in?am-mation by commensal bacteria.A study using an animal model of colorectal carcinoma,IL-10?/?mice exposed to the carcino-gen,azoxymethane(AOM)tested this hypothesis.In this study, AOM-exposed IL-10?/?mice developed colorectal carcinomas when housed conventionally,but not when housed under GF con-ditions.Furthermore,MyD88(an adaptor molecule necessary for most TLR signaling)was found to be essential in this process,sug-gesting that bacterial-induced in?ammation in the intestine can play a crucial role in the development of the carcinomas(Uro-nis et al.,2009).Interestingly,ingestion of lactic acid-producing bacteria has been shown to prevent carcinogen-induced lesions and tumors in animal models(Goldin and Gorbach,1980;Goldin et al.,1996;Pool-Zobel et al.,1996;Challa et al.,1997;Rowland et al.,1998).However,the epidemiologic studies are controversial in humans;some studies have found no association(Kampman et al.,1994a,b;Kearney et al.,1996),whereas others have found a signi?cant association(Malhotra,1977;Peters et al.,1992;Boutron et al.,1996)between consumption of fermented milk products and occurrence of colon cancer.Further studies are,therefore,needed to determine if probiotics can be used as protective agents for the prevention of human colon cancer.

Unlike the situation in autoimmune and allergic diseases, there is little evidence that the microbiota directly affects the immune response against tumors,and consequently,somehow

impacts tumor progression.One can,however,speculate that the type of immune response generated by the gut commen-sal bacteria could potentially in?uence tumor immunity.For example,mice colonized with enterotoxigenic B.fragilis exhibit colonic Th17in?ammatory in?ltrates that are involved in induc-tion of colon tumors,as indicated by inhibition of colon tumor formation following treatment with anti-IL-17antibody(Wu et al.,2009).Moreover,Th17cells have been found in cellular in?ltrations in a variety of tumors,including prostate(Sfanos et al.,2008),pancreatic(Gnerlich et al.,2010),and ovarian cancer(Kryczek et al.,2009a),and in stomach cancer and the lymph nodes draining gastric cancer sites(Zhang et al.,2008). The frequency of Th17cells correlates with the clinical stage of gastric cancer,i.e.,Th17cells are found at higher levels in late stage versus early stage(Zhang et al.,2008).On the other hand,Th17cells appear to have a bene?cial role in human ovarian cancer(Kryczek et al.,2009a)and murine melanoma, pancreatic,and colon cancer(Muranski et al.,2008;Kryczek et al.,2009b;Gnerlich et al.,2010).It is,therefore,possible that a microbiota favoring commensal bacteria that induces a Th17response could have differential effects on tumors depend-ing on the type of tumor or the stage of tumor develop-ment,and as found for autoimmunity and allergy,could alter the immune response to tumors at extra-intestinal as well as intestinal sites.

CONCLUSION

Genetic and environmental factors appear to shape the compo-sition of the gut microbiota,which in turn plays a very impor-tant role in shaping the immune response at both intestinal and extra-intestinal sites,and in controlling the development of some types of autoimmune and allergic diseases as well as some forms of cancer.Therefore,any external factor that can alter the gut microbiota balance,such as diet or antibiotic treatment,should be viewed as a potential risk factor for development of these in?am-matory diseases.Any alteration of the microbiota that leads to (1)a reduction in commensal bacteria favoring regulatory cells (Foxp3+or other,e.g.,rTh17)or(2)an enrichment in commen-sal bacteria favoring the induction of potential pathogenic cells may elicit disease in genetically susceptible individuals(Figure1). However,the relationship between gut microbiota,immunity,and disease is very complex,since the same commensal bacteria can induce a protective response or a pathogenic response depending on the susceptibility of the individual.SFB is the perfect exam-ple,since it is protective in type1diabetes,but causes disease in mouse models of EAE or arthritis.The speci?c commensal microorganisms that contribute to either the etiology of or pro-tection from many different types of diseases have not yet been fully identi?ed and described.Future studies aimed at determin-ing the impact of speci?c commensal bacteria on the immune response and induction of in?ammatory diseases are crucial for a better understanding of pathogenesis of these diseases.Further-more,an understanding of the genetic and environmental factors that shape the composition of the microbiota will provide the basis for strategies that will allow for the manipulation of microbiota in individuals at risk of developing disease.With this information in hand,it should be possible to design novel tailored therapies capa-ble of preventing disease development in high risk individuals and treating established disease in already sick patients.Although not discussed in this review,other microorganisms,such as fungi

and

FIGURE1|Impact of the composition of the?ora on the immune

response and disease development.Dysbiosis can arise from either(1)a

reduction in Treg-inducing bacteria(e.g.,Bi?dobacteria or Bacteroides)that

results in decreased Tregs,but unchanged levels of Teff cells;or(2)an

enrichment in pro-in?ammatory bacteria(e.g.,SFB)that results in increased

Teff cells,but unchanged levels of Tregs.In both cases,the Treg:Teff cell

balance is biased toward the Teff cells,and the outcome of this imbalance can

be development of disease in genetically susceptible individuals.

viruses,are present in the intestine,and have also been shown to be involved in autoimmune disease or allergic disease pathogenesis in susceptible animals(Noverr et al.,2004;Cadwell et al.,2010).It would,therefore,be very important in the future to extend the studies cited above to these microorganisms rather than limiting them to commensal bacteria only.It may eventually be possible to establish pro?les of the microbiota in humans based on the bacterial species composition or enterotypes(Arumugam et al., 2011).This“biological?ngerprint”of the future,similar to blood or tissue typing,may be used to predict responses to drugs or diet as well as aid in disease diagnosis/prognosis,and could ultimately lead to the development of personalized therapies.

REFERENCES

Alard,P.,Parnell,S.A.,Manirarora,J.

N.,and Kosiewicz,M.M.(2009).

Probiotics control lupus progression via induction of regulatory cells and IL-10production.J.Immunol.182,

50.30.

Arumugam,M.,Raes,J.,Pelletier,E., Le Paslier,D.,Yamada,T.,Mende,

D.R.,Fernandes,G.R.,Tap,J.,

Bruls,T.,Batto,J.M.,Bertalan,M., Borruel,N.,Casellas,F.,Fernandez, L.,Gautier,L.,Hansen,T.,Hattori, M.,Hayashi,T.,Kleerebezem,M., Kurokawa,K.,Leclerc,M.,Levenez,

F.,Manichanh,C.,Nielsen,H.B.,

Nielsen,T.,Pons,N.,Poulain,J., Qin,J.,Sicheritz-Ponten,T.,Tims, S.,Torrents, D.,Ugarte, E.,Zoe-tendal, E.G.,Wang,J.,Guarner,

F.,Pedersen,O.,De Vos,W.M.,

Brunak,S.,Dore,J.,Consortium, M.,Weissenbach,J.,Ehrlich,S.D., Bork,P.,Antolin,M.,Artiguenave,

F.,Blottiere,H.M.,Almeida,M.,

Brechot,C.,Cara,C.,Chervaux,C., Cultrone,A.,Delorme,C.,Denar-iaz,G.,Dervyn,R.,Foerstner,K.

U.,Friss,C.,Van De Guchte,M., Guedon,E.,Haimet,F.,Huber,W., Van Hylckama-Vlieg,J.,Jamet,A., Juste,C.,Kaci,G.,Knol,J.,Lakhdari, O.,Layec,S.,Le Roux,K.,Maguin,

E.,Merieux,A.,Melo Minardi,R.,

M’Rini,C.,Muller,J.,Oozeer,R., Parkhill,J.,Renault,P.,Rescigno,M., Sanchez,N.,Sunagawa,S.,Torrejon,

A.,Turner,K.,Vandemeulebrouck,

G.,Varela,E.,Winogradsky,Y.,and

Zeller,G.(2011).Enterotypes of the human gut microbiome.Nature43, 174–180.

Asher,M.I.(1998).Worldwide varia-tions in the prevalence of asthma symptoms:the International Study of Asthma and Allergies in Child-hood(ISAAC).Eur.Respir.J.12, 315–335.

Atarashi,K.,Tanoue,T.,Shima,T., Imaoka,A.,Kuwahara,T.,Momose, Y.,Cheng,G.,Yamasaki,S.,Saito,T., Ohba,Y.,Taniguchi,T.,Takeda,K., Hori,S.,Ivanov,Ii,Umesaki,Y.,Itoh, K.,and Honda,K.(2011).Induc-tion of colonic regulatory T cells by indigenous Clostridium species.

Science331,337–341.

Baharav,E.,Mor,F.,Halpern,M.,and Weinberger,A.(2004).Lactobacillus GG bacteria ameliorate arthritis in Lewis rats.J.Nutr.134,1964–1969.Balmer,S.E.,and Wharton,B.A.(1989).

Diet and faecal?ora in the newborn:

breast milk and infant formula.Arch.

Dis.Child.64,1672–1677.

Bauer,H.,Horowitz,R.E.,Levenson,

S.M.,and Popper,H.(1963).The

response of the lymphatic tissue

to the microbial?ora.Studies on

germfree mice.Am.J.Pathol.42,

471–483.

Beasley,R.,Crane,J.,Lai,C.K.,and

Pearce,N.(2000).Prevalence and

etiology of asthma.J.Allergy Clin.

Immunol.105,S466–S472.

Bending, D.,De La Pena,H.,Veld-

hoen,M.,Phillips,J.M.,Uytten-

hove,C.,Stockinger,B.,and Cooke,

A.(2009).Highly puri?ed Th17cells

from BDC2.5NOD mice convert

into Th1-like cells in NOD/SCID

recipient mice.J.Clin.Invest.119,

565–572.

Bennet,R.,and Nord,C.E.(1987).

Development of the faecal anaer-

obic micro?ora after caesarean

section and treatment with antibi-

otics in newborn infants.Infection

15,332–336.

Bingham,S.A.(2000).Diet and colorec-

tal cancer prevention.Biochem.Soc.

Trans.28,12–16.

Bjorksten,B.,Naaber,P.,Sepp,E.,and

Mikelsaar,M.(1999).The intestinal

micro?ora in allergic Estonian and

Swedish2-year-old children.Clin.

Exp.Allergy29,342–346.

Bjorksten, B.,Sepp, E.,Julge,K.,

Voor,T.,and Mikelsaar,M.(2001).

Allergy development and the intesti-

nal micro?ora during the?rst year

of life.J.Allergy Clin.Immunol.108,

516–520.

Bouskra,D.,Brezillon,C.,Berard,M.,

Werts,C.,Varona,R.,Boneca,I.G.,

and Eberl,G.(2008).Lymphoid tis-

sue genesis induced by commensals

through NOD1regulates intestinal

homeostasis.Nature456,507–510.

Boutron,M. C.,Faivre,J.,Marteau,

P.,Couillault,C.,Senesse,P.,and

Quipourt,V.(1996).Calcium,phos-

phorus,vitamin D,dairy prod-

ucts and colorectal carcinogenesis:a

French case–control study.Br.J.

Cancer74,145–151.

Breban,M.A.,Moreau,M.C.,Fournier,

C.,Ducluzeau,R.,and Kahn,M.

F.(1993).In?uence of the bacterial

?ora on collagen-induced arthritis

in susceptible and resistant strains of

rats.Clin.Exp.Rheumatol.11,61–64.

Buljevac,D.,Van Doornum,G.J.,Flach,

H.Z.,Groen,J.,Osterhaus,A.D.,

Hop,W.,Van Doorn,P.A.,Van Der

Meche,F.G.,and Hintzen,R.Q.

(2005).Epstein-Barr virus and dis-

ease activity in multiple sclerosis.

J.Neurol.Neurosurg.Psychiatr.76,

1377–1381.

Cadwell,K.,Patel,K.K.,Maloney,N.

S.,Liu,T.C.,Ng,A.C.,Storer,C.

E.,Head,R.D.,Xavier,R.,Stappen-

beck,T.S.,and Virgin,H.W.(2010).

Virus-plus-susceptibility gene inter-

action determines Crohn’s disease

gene Atg16L1phenotypes in intes-

tine.Cell141,1135–1145.

Calcinaro,F.,Dionisi,S.,Marinaro,M.,

Candeloro,P.,Bonato,V.,Marzotti,

S.,Corneli,R.B.,Ferretti,E.,Gulino,

A.,Grasso,F.,De Simone,C.,Di

Mario,U.,Falorni,A.,Boirivant,M.,

and Dotta,F.(2005).Oral probiotic

administration induces interleukin-

10production and prevents spon-

taneous autoimmune diabetes in

the non-obese diabetic mouse.Dia-

betologia48,1565–1575.

Cavallo,T.,and Granholm,N. A.

(1990).Lipopolysaccharide from

Gram-negative bacteria enhances

polyclonal B cell activation and exac-

erbates nephritis in MRL/lpr mice.

Clin.Exp.Immunol.82,515–521.

Cermelli,C.,and Jacobson,S.(2000).

Viruses and multiple sclerosis.Viral

Immunol.13,255–267.

Challa,A.,Rao,D.R.,Chawan,C.B.,

and Shackelford,L.(1997).Bi?-

dobacterium longum and lactulose

suppress azoxymethane-induced

colonic aberrant crypt foci in rats.

Carcinogenesis18,517–521.

Chen,W.,Li,D.,Paulus,B.,Wilson,I.,

and Chadwick,V.S.(2000).Detec-

tion of Listeria monocytogenes by

polymerase chain reaction in intesti-

nal mucosal biopsies from patients

with in?ammatory bowel disease

and controls.J.Gastroenterol.Hepa-

tol.15,1145–1150.

Codarri,L.,Gyulveszi,G.,Tosevski,

V.,Hesske,L.,Fontana,A.,Mag-

nenat,L.,Suter,T.,and Becher,B.

(2011).RORgammat drives produc-

tion of the cytokine GM-CSF in

helper T cells,which is essential for

the effector phase of autoimmune

neuroin?ammation.Nat.Immunol.

12,560–567.

Dalpke,A.,Frank,J.,Peter,M.,and Heeg,

K.(2006).Activation of toll-like

receptor9by DNA from different

bacterial species.Infect.Immun.74,

940–946.

Davis, C. D.,and Milner,J. A.

(2009).Gastrointestinal micro?ora,

food components and colon can-

cer prevention.J.Nutr.Biochem.20,

743–752.

De Filippo,C.,Cavalieri,D.,Di Paola,

M.,Ramazzotti,M.,Poullet,J.B.,

Massart,S.,Collini,S.,Pieraccini,

G.,and Lionetti,P.(2010).Impact

of diet in shaping gut microbiota

revealed by a comparative study

in children from Europe and rural

Africa.Proc.Natl.Acad.Sci.U.S.A.

107,14691–14696.

Di Giacinto,C.,Marinaro,M.,Sanchez,

M.,Strober,W.,and Boirivant,M.

(2005).Probiotics ameliorate recur-

rent Th1-mediated murine coli-

tis by inducing IL-10and IL-10-

dependent TGF-beta-bearing reg-

ulatory cells.J.Immunol.174,

3237–3246.

Dominguez-Bello,M.G.,Costello,E.K.,

Contreras,M.,Magris,M.,Hidalgo,

G.,Fierer,N.,and Knight,R.(2010).

Delivery mode shapes the acqui-

sition and structure of the ini-

tial microbiota across multiple body

habitats in newborns.Proc.Natl.

Acad.Sci.U.S.A.107,11971–11975.

El-Behi,M.,Ciric, B.,Dai,H.,Yan,

Y.,Cullimore,M.,Safavi,F.,Zhang,

G.X.,Dittel,B.N.,and Rostami,

A.(2011).The encephalitogenicity

of T(H)17cells is dependent on

IL-1-and IL-23-induced produc-

tion of the cytokine GM-CSF.Nat.

Immunol.12,568–575.

Esplugues,E.,Huber,S.,Gagliani,N.,

Hauser,A. E.,Town,T.,Wan,Y.

Y.,O’Connor,W.,Rongvaux, A.,

Van Rooijen,N.,Haberman,A.M.,

Iwakura,Y.,Kuchroo,V.K.,Kolls,J.

K.,Bluestone,J.A.,Herold,K.C.,

and Flavell,R.A.(2011).Control

of T(H)17cells occurs in the small

intestine.Nature475,514–518.

FAO/WHO.(2002).Guidelines for the

Evaluation of Probiotics in Food.

Available at:http://www.who.int/

foodsafety/publications/fs_manage

ment/probiotics2/en/index.html

Farrell,R. A.,Antony, D.,Wall,G.

R.,Clark,D.A.,Fisniku,L.,Swan-

ton,J.,Khaleeli,Z.,Schmierer,K.,

Miller,D.H.,and Giovannoni,G.

(2009).Humoral immune response

to EBV in multiple sclerosis is

associated with disease activity on MRI.Neurology73,32–38. Feleszko,W.,Jaworska,J.,Rha,R.D., Steinhausen,S.,Avagyan,A.,Jaud-szus,A.,Ahrens,B.,Groneberg,D.

A.,Wahn,U.,and Hamelmann,E.

(2007).Probiotic-induced suppres-sion of allergic sensitization and airway in?ammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma.Clin.Exp.Allergy 37,498–505.

Feng,T.,Wang,L.,Schoeb,T.R.,Elson,

C.O.,and Cong,Y.(2010).Micro-

biota innate stimulation is a prereq-uisite for T cell spontaneous prolifer-ation and induction of experimental colitis.J.Exp.Med.207,1321–1332. Ferlay,J.,Autier,P.,Boniol,M.,Heanue, M.,Colombet,M.,and Boyle,P.

(2007).Estimates of the cancer inci-dence and mortality in Europe in 2006.Ann.Oncol.18,581–592. Filippi, C.,and von Herrath,M.

(2005).How viral infections affect the autoimmune process leading to type1diabetes.Cell.Immunol.233, 125–132.

Forsythe,P.,Inman,M.D.,and Bienen-stock,J.(2007).Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice.

Am.J.Respir.Crit.Care Med.175, 561–569.

Frank, D.N.,St Amand, A.L., Feldman,R. A.,Boedeker, E. C., Harpaz,N.,and Pace,N.R.(2007).

Molecular-phylogenetic characteri-zation of microbial community imbalances in human in?ammatory bowel diseases.Proc.Natl.Acad.Sci.

U.S.A.104,13780–13785. Gaboriau-Routhiau,V.,Rakotobe,S., Lecuyer, E.,Mulder,I.,Lan, A., Bridonneau,C.,Rochet,V.,Pisi,A., De Paepe,M.,Brandi,G.,Eberl,

G.,Snel,J.,Kelly, D.,and Cerf-

Bensussan,N.(2009).The key role of segmented?lamentous bacteria in the coordinated maturation of gut helper T cell responses.Immunity 31,677–689.

Gilden,D.H.(2005).Infectious causes of multiple https://www.sodocs.net/doc/0a15105227.html,ncet Neurol.

4,195–202.

Gnerlich,J.L.,Mitchem,J.B.,Weir,J.S., Sankpal,N.V.,Kashiwagi,H.,Belt,

B.A.,Porembka,M.R.,Herndon,

J.M.,Eberlein,T.J.,Goedegebu-ure,P.,and Linehan,D.C.(2010).

Induction of Th17cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer.J.Immunol.185, 4063–4071.

Goldin, B.R.,and Gorbach,S.L.

(1980).Effect of Lactobacillus aci-dophilus dietary supplements

on1,2-dimethylhydrazine

dihydrochloride-induced intestinal

cancer in rats.J.Natl.Cancer Inst.

64,263–265.

Goldin,B.R.,Gualtieri,L.J.,and Moore,

R.P.(1996).The effect of Lactobacil-

lus GG on the initiation and pro-

motion of DMH-induced intestinal

tumors in the rat.Nutr.Cancer25,

197–204.

Hall,J.A.,Bouladoux,N.,Sun,C.M.,

Wohlfert,E.A.,Blank,R.B.,Zhu,

Q.,Grigg,M.E.,Berzofsky,J.A.,and

Belkaid,Y.(2008).Commensal DNA

limits regulatory T cell conversion

and is a natural adjuvant of intestinal

immune responses.Immunity29,

637–649.

Han,G.,Wang,R.,Chen,G.,Wang,J.,

Xu,R.,Wang,L.,Feng,J.,Li,X.,

Guo,R.,Fu,L.,Shen,B.,and Li,

Y.(2010).Interleukin-17-producing

gammadelta+T cells protect NOD

mice from type1diabetes through

a mechanism involving transform-

ing growth factor-beta.Immunology

129,197–206.

Harmsen,H.J.,Wildeboer-Veloo,A.C.,

Raangs,G.C.,Wagendorp,A.A.,

Klijn,N.,Bindels,J.G.,and Welling,

G.W.(2000).Analysis of intestinal

?ora development in breast-fed and

formula-fed infants by using mol-

ecular identi?cation and detection

methods.J.Pediatr.Gastroenterol.

Nutr.30,61–67.

Hill, D. A.,Hoffmann, C.,Abt,M.

C.,Du,Y.,Kobuley,

D.,Kirn,T.

J.,Bushman, F. D.,and Artis,

D.(2010).Metagenomic analyses

reveal antibiotic-induced temporal

and spatial changes in intestinal

microbiota with associated alter-

ations in immune cell homeostasis.

Mucosal Immunol.3,148–158.

Hopkins,M.J.,Macfarlane,G.T.,

Furrie, E.,Fite, A.,and Macfar-

lane,S.(2005).Characterisation of

intestinal bacteria in infant stools

using real-time PCR and northern

hybridisation analyses.FEMS Micro-

biol.Ecol.54,77–85.

Hyttinen,V.,Kaprio,J.,Kinnunen,L.,

Koskenvuo,M.,and Tuomilehto,J.

(2003).Genetic liability of type1

diabetes and the onset age among

22,650young Finnish twin pairs:

a nationwide follow-up study.Dia-

betes52,1052–1055.

Ishikawa,H.,Tanaka,K.,Maeda,Y.,

Aiba,Y.,Hata, A.,Tsuji,N.M.,

Koga,Y.,and Matsumoto,T.(2008).

Effect of intestinal microbiota on

the induction of regulatory CD25+

CD4+T cells.Clin.Exp.Immunol.

153,127–135.

Ivanov,I.I.,Atarashi,K.,Manel,N.,

Brodie,E.L.,Shima,T.,Karaoz,U.,

Wei,D.,Goldfarb,K.C.,Santee,C.

A.,Lynch,S.V.,Tanoue,T.,Imaoka,

A.,Itoh,K.,Takeda,K.,Umesaki,

Y.,Honda,K.,and Littman,D.R.

(2009).Induction of intestinal Th17

cells by segmented?lamentous bac-

teria.Cell139,485–498.

Ivanov,I.I.,Frutos Rde,L.,Manel,N.,

Y oshinaga,K.,Rifkin,D.B.,Sartor,

R.B.,Finlay,B.B.,and Littman,

D.R.(2008).Speci?c microbiota

direct the differentiation of IL-

17-producing T-helper cells in the

mucosa of the small intestine.Cell

Host Microbe4,337–349.

Jacobs,J.P.,Wu,H.J.,Benoist,C.,and

Mathis,D.(2009).IL-17-producing

T cells can augment autoantibody-

induced arthritis.Proc.Natl.Acad.

Sci.U.S.A.106,21789–21794.

Jakobsson,H.E.,Jernberg,C.,Ander-

sson,A.F.,Sjolund-Karlsson,M.,

Jansson,J.K.,and Engstrand,

L.(2010).Short-term antibi-

otic treatment has differing

long-term impacts on the

human throat and gut micro-

biome.PLoS ONE5,e9836.doi:

10.1371/journal.pone.0009836

Jernberg,C.,Lofmark,S.,Edlund,C.,

and Jansson,J.K.(2007).Long-

term ecological impacts of antibi-

otic administration on the human

intestinal microbiota.ISME J.1,

56–66.

Kalliomaki,M.,Salminen,S.,

Arvilommi,H.,Kero,P.,Koski-

nen,P.,and Isolauri, E.(2001).

Probiotics in primary prevention

of atopic disease:a randomised

placebo-controlled https://www.sodocs.net/doc/0a15105227.html,ncet357,

1076–1079.

Kalliomaki,M.,Salminen,S.,Poussa,

T.,Arvilommi,H.,and Isolauri,E.

(2003).Probiotics and prevention

of atopic disease:4-year follow-up

of a randomised placebo-controlled

https://www.sodocs.net/doc/0a15105227.html,ncet361,1869–1871.

Kampman,E.,Goldbohm,R.A.,Van

Den Brandt,P.A.,and Van’T Veer,

P.(1994a).Fermented dairy prod-

ucts,calcium,and colorectal cancer

in The Netherlands Cohort Study.

Cancer Res.54,3186–3190.

Kampman,E.,Van’T Veer,P.,Hiddink,

G.J.,Van Aken-Schneijder,P.,Kok,

F.J.,and Hermus,R.J.(1994b).

Fermented dairy products,dietary

calcium and colon cancer:a case-

control study in The Netherlands.

Int.J.Cancer59,170–176.

Karimi,K.,Inman,M.D.,Bienenstock,

J.,and Forsythe,P.(2009).Lacto-

bacillus reuteri-induced regulatory T

cells protect against an allergic air-

way response in mice.Am.J.Respir.

Crit.Care Med.179,186–193.

Kato,I.,Endo-Tanaka,K.,and

Y okokura,T.(1998).Suppressive

effects of the oral administration

of Lactobacillus casei on type II

collagen-induced arthritis in DBA/1

mice.Life Sci.63,635–644.

Kearney,J.,Giovannucci,E.,Rimm,E.

B.,Ascherio,A.,Stampfer,M.J.,

Colditz,G.A.,Wing,A.,Kampman,

E.,and Willett,W.C.(1996).Cal-

cium,vitamin D,and dairy foods

and the occurrence of colon can-

cer in men.Am.J.Epidemiol.143,

907–917.

Kirjavainen,P.V.,Apostolou,E.,Arvola,

T.,Salminen,S.J.,Gibson,G.R.,

and Isolauri,E.(2001).Character-

izing the composition of intestinal

micro?ora as a prospective treat-

ment target in infant allergic disease.

FEMS Immunol.Med.Microbiol.32,

1–7.

Kirjavainen,P.V.,Apostolou,E.,Salmi-

nen,S.J.,and Isolauri,E.(1999).

New aspects of probiotics–a novel

approach in the management of

food allergy.Allergy54,909–915.

Klaasen,H.L.,Koopman,J.P.,Van

Den Brink,M.E.,Bakker,M.H.,

Poelma,F.G.,and Beynen,A.C.

(1993a).Intestinal,segmented,?la-

mentous bacteria in a wide range

of vertebrate https://www.sodocs.net/doc/0a15105227.html,b.Anim.27,

141–150.

Klaasen,H.L.,Van Der Heijden,P.J.,

Stok,W.,Poelma,F.G.,Koopman,

J.P.,Van Den Brink,M.E.,Bakker,

M.H.,Eling,W.M.,and Beynen,

A.C.(1993b).Apathogenic,intesti-

nal,segmented,?lamentous bacte-

ria stimulate the mucosal immune

system of mice.Infect.Immun.61,

303–306.

Koenig,J.E.,Spor,A.,Scalfone,N.,

Fricker,A.D.,Stombaugh,J.,Knight,

R.,Angenent,L.T.,and Ley,R.

E.(2011).Succession of micro-

bial consortia in the developing

infant gut microbiome.Proc.Natl.

Acad.Sci.U.S.A.108(Suppl.1),

4578–4585.

Kriegel,M. A.,Se?k, E.,Hill,J.

A.,Wu,H.J.,Benoist, C.,and

Mathis,D.(2011).Naturally trans-

mitted segmented?lamentous bac-

teria segregate with diabetes pro-

tection in nonobese diabetic mice.

Proc.Natl.Acad.Sci.U.S.A.108,

11548–11553.

Kryczek,I.,Banerjee,M.,Cheng,P.,

Vatan,L.,Szeliga,W.,Wei,S.,

Huang,E.,Finlayson,E.,Simeone,

D.,Welling,T.H.,Chang,A.,Coukos,

G.,Liu,R.,and Zou,W.(2009a).

Phenotype,distribution,generation,

and functional and clinical rele-

vance of Th17cells in the human

tumor environments.Blood114,

1141–1149.

Kryczek,I.,Wei,S.,Szeliga,W.,Vatan,

L.,and Zou,W.(2009b).Endoge-

nous IL-17contributes to reduced

tumor growth and metastasis.Blood 114,357–359.

Laan,M.,Cui,Z.H.,Hoshino,H.,Lot-vall,J.,Sjostrand,M.,Gruenert,D.

C.,Skoogh,B.E.,and Linden,A.

(1999).Neutrophil recruitment by human IL-17via C-X-C chemokine release in the airways.J.Immunol.

162,2347–2352.

Laan,M.,Prause,O.,Miyamoto,M., Sjostrand,M.,Hytonen, A.M., Kaneko,T.,Lotvall,J.,and Linden,

A.(2003).A role of GM-CSF in the

accumulation of neutrophils in the airways caused by IL-17and TNF-alpha.Eur.Respir.J.21,387–393. Lavasani,S.,Dzhambazov,B.,Nouri, M.,Fak,F.,Buske,S.,Molin,G., Thorlacius,H.,Alenfall,J.,Jepps-son,B.,and Westrom,B.(2010).

A novel probiotic mixture exerts

a therapeutic effect on experimen-

tal autoimmune encephalomyelitis mediated by IL-10producing regu-latory T cells.PLoS ONE5,e9009.

doi:10.1371/journal.pone.0009009 Lee,Y.K.,Menezes,J.S.,Umesaki, Y.,and Mazmanian,S.K.(2011).

Proin?ammatory T-cell responses to gut microbiota promote experimen-tal autoimmune encephalomyelitis.

Proc.Natl.Acad.Sci.U.S.A.

108(Suppl.1),4615–4622.

Ley,R. E.,Hamady,M.,Lozupone,

C.,Turnbaugh,P.J.,Ramey,R.R.,

Bircher,J.S.,Schlegel,M.L.,Tucker, T.A.,Schrenzel,M.D.,Knight,R., and Gordon,J.I.(2008).Evolution of mammals and their gut microbes.

Science320,1647–1651. Livingston,M.,Loach, D.,Wilson, M.,Tannock,G.W.,and Baird, M.(2010).Gut commensal Lacto-bacillus reuteri100-23stimulates an immunoregulatory response.

Immunol.Cell Biol.88,99–102. Lodinova-Zadnikova,R.,Cukrowska,

B.,and Tlaskalova-Hogenova,H.

(2003).Oral administration of pro-biotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life(after 10and20years).Int.Arch.Allergy Immunol.131,209–211. Lubberts,E.,Koenders,M.I.,Oppers-Walgreen,B.,Van Den Bersselaar, L.,Coenen-De Roo,C.J.,Joosten, L.A.,and Van Den Berg,W. B.

(2004).Treatment with a neutraliz-ing anti-murine interleukin-17anti-body after the onset of collagen-induced arthritis reduces joint in?ammation,cartilage destruction, and bone erosion.Arthritis Rheum.

50,650–659.

Lyons,A.,O’Mahony,D.,O’Brien,F., Macsharry,J.,Sheil,B.,Ceddia,M., Russell,W.M.,Forsythe,P.,Bienen-stock,J.,Kiely, B.,Shanahan, F., and O’Mahony,L.(2010).Bacterial

strain-speci?c induction of Foxp3+

T regulatory cells is protective in

murine allergy models.Clin.Exp.

Allergy40,811–819.

Macpherson,A.J.,and Harris,N.L.

(2004).Interactions between com-

mensal intestinal bacteria and the

immune system.Nat.Rev.Immunol.

4,478–485.

Majamaa,H.,and Isolauri,E.(1997).

Probiotics:a novel approach in

the management of food allergy.J.

Allergy Clin.Immunol.99,179–185.

Malhotra,S.L.(1977).Dietary factors

in a study of cancer colon from can-

cer registry,with special reference to

the role of saliva,milk and fermented

milk products and vegetable?bre.

Med.Hypotheses3,122–126.

Mandar,R.,and Mikelsaar,M.(1996).

Transmission of mother’s micro?ora

to the newborn at birth.Biol.

Neonate69,30–35.

Manirarora,J.N.,Parnell,S.A.,Hu,Y.-

H.,Kosiewicz,M.M.,and Alard,P.

(2011).NOD dendritic cells stimu-

lated with lactobacilli preferentially

produce IL-10versus IL-12and

decrease diabetes incidence.Clin.

Dev.Immunol.2011,630187.

Mannino,D.M.,Homa,D.M.,Per-

towski,C.A.,Ashizawa,A.,Nixon,

L.L.,Johnson,C.A.,Ball,L.B.,Jack,

E.,and Kang,D.S.(1998).Surveil-

lance for asthma–United States,

1960–1995.MMWR CDC Surveill.

Summ.47,1–27.

Martin-Orozco,N.,Chung,Y.,Chang,

S.H.,Wang,Y.H.,and Dong,C.

(2009).Th17cells promote pancre-

atic in?ammation but only induce

diabetes ef?ciently in lymphopenic

hosts after conversion into Th1cells.

Eur.J.Immunol.39,216–224.

Matsuzaki,T.,Nagata,Y.,Kado,S.,

Uchida,K.,Kato,I.,Hashimoto,S.,

and Y okokura,T.(1997).Prevention

of onset in an insulin-dependent

diabetes mellitus model,NOD mice,

by oral feeding of Lactobacillus casei.

APMIS105,643–649.

Mazmanian,S.K.,Liu,C.H.,Tziana-

bos,A.O.,and Kasper,D.L.(2005).

An immunomodulatory molecule of

symbiotic bacteria directs matura-

tion of the host immune system.Cell

122,107–118.

Mazmanian,S.K.,Round,J.L.,and

Kasper,D.L.(2008).A microbial

symbiosis factor prevents intestinal

in?ammatory disease.Nature453,

620–625.

Muranski,P.,Boni,A.,Antony,P.A.,

Cassard,L.,Irvine,K.R.,Kaiser,

A.,Paulos,C.M.,Palmer,D.C.,

Touloukian,C. E.,Ptak,K.,Gat-

tinoni,L.,Wrzesinski, C.,Hin-

richs, C.S.,Kerstann,K.W.,

Feigenbaum,L.,Chan,C.C.,and

Restifo,N.P.(2008).Tumor-speci?c

Th17-polarized cells eradicate large

established melanoma.Blood112,

362–373.

Nikoopour,E.,Schwartz,J.A.,Huszarik,

K.,Sandrock,C.,Krougly,O.,Lee-

Chan,E.,and Singh,B.(2010).Th17

polarized cells from nonobese dia-

betic mice following mycobacter-

ial adjuvant immunotherapy delay

type1diabetes.J.Immunol.184,

4779–4788.

Noverr,M.C.,and Huffnagle,G.B.

(2005).The“micro?ora hypothesis”

of allergic diseases.Clin.Exp.Allergy

35,1511–1520.

Noverr,M.C.,Noggle,R.M.,Toews,

G.B.,and Huffnagle,G.B.(2004).

Role of antibiotics and fungal micro-

biota in driving pulmonary aller-

gic responses.Infect.Immun.72,

4996–5003.

Ochoa-Reparaz,J.,Mielcarz, D.W.,

Ditrio,L. E.,Burroughs, A.R.,

Foureau,D.M.,Haque-Begum,S.,

and Kasper,L.H.(2009).Role

of gut commensal micro?ora in

the development of experimental

autoimmune encephalomyelitis.J.

Immunol.183,6041–6050.

Ochoa-Reparaz,J.,Mielcarz, D.W.,

Wang,Y.,Begum-Haque,S.,Das-

gupta,S.,Kasper,D.L.,and Kasper,L.

H.(2010).A polysaccharide from the

human commensal Bacteroides frag-

ilis protects against CNS demyeli-

nating disease.Mucosal Immunol.3,

487–495.

Okada,H.,Kuhn,C.,Feillet,H.,and

Bach,J. F.(2010).The“hygiene

hypothesis”for autoimmune and

allergic diseases:an update.Clin.

Exp.Immunol.160,1–9.

O’Keefe,S.J.,Ou,J.,Aufreiter,S.,

O’Connor,D.,Sharma,S.,Sepul-

veda,J.,Fukuwatari,T.,Shibata,K.,

and Mawhinney,T.(2009).Products

of the colonic microbiota mediate

the effects of diet on colon cancer

risk.J.Nutr.139,2044–2048.

O’Mahony,C.,Scully,P.,O’Mahony,D.,

Murphy,S.,O’Brien,F.,Lyons,A.,

Sherlock,G.,Macsharry,J.,Kiely,

B.,Shanahan, F.,and O’Mahony,

L.(2008).Commensal-induced reg-

ulatory T cells mediate protec-

tion against pathogen-stimulated

NF-kappaB activation.PLoS Pathog.

4,e1000112.doi:10.1371/jour-

nal.ppat.1000112

Onderdonk, A. B.,Steeves,R.M.,

Cisneros,R.L.,and Bronson,R.

T.(1984).Adoptive transfer of

immune enhancement of exper-

imental ulcerative colitis.Infect.

Immun.46,64–67.

Oyama,N.,Sudo,N.,Sogawa,H.,

and Kubo, C.(2001).Antibiotic

use during infancy promotes a

shift in the T(H)1/T(H)2balance

toward T(H)2-dominant immunity

in mice.J.Allergy Clin.Immunol.

107,153–159.

Packey,C.D.,and Sartor,R.B.(2008).

Interplay of commensal and path-

ogenic bacteria,genetic mutations,

and immunoregulatory defects in

the pathogenesis of in?ammatory

bowel diseases.J.Intern.Med.263,

597–606.

Palmer,C.,Bik,E.M.,Digiulio,D.B.,

Relman,D.A.,and Brown,P.O.

(2007).Development of the human

infant intestinal microbiota.PLoS

Biol.5,e177.doi:10.1371/jour-

nal.pbio.0050177

Penders,J.,Thijs,C.,Vink,C.,Stelma,

F.F.,Snijders,B.,Kummeling,I.,Van

Den Brandt,P.A.,and Stobberingh,

E.E.(2006).Factors in?uencing the

composition of the intestinal micro-

biota in early infancy.Pediatrics118,

511–521.

Peters,R.K.,Pike,M.C.,Garabrant,D.,

and Mack,T.M.(1992).Diet and

colon cancer in Los Angeles County,

California.Cancer Causes Control3,

457–473.

Pineton de Chambrun,G.,Colombel,

J.F.,Poulain,D.,and Darfeuille-

Michaud, A.(2008).Pathogenic

agents in in?ammatory bowel dis-

eases.Curr.Opin.Gastroenterol.24,

440–447.

Poole,B.D.,Sco?eld,R.H.,Harley,J.B.,

and James,J.A.(2006).Epstein-Barr

virus and molecular mimicry in sys-

temic lupus erythematosus.Autoim-

munity39,63–70.

Pool-Zobel, B.L.,Neudecker, C.,

Domizlaff,I.,Ji,S.,Schillinger,

U.,Rumney, C.,Moretti,M.,

Vilarini,I.,Scassellati-Sforzolini,

R.,and Rowland,I.(1996).

Lactobacillus-and Bi?dobacterium-

mediated antigenotoxicity in the

colon of rats.Nutr.Cancer26,

365–380.

Rabizadeh,S.,Rhee,K.J.,Wu,S.,

Huso, D.,Gan, C.M.,Golub,J.

E.,Wu,X.,Zhang,M.,and Sears,

C.L.(2007).Enterotoxigenic Bac-

teroides fragilis:a potential instigator

of colitis.In?amm.Bowel Dis.13,

1475–1483.

Rajilic-Stojanovic,M.,Smidt,H.,and

De Vos,W.M.(2007).Diver-

sity of the human gastrointestinal

tract microbiota revisited.Environ.

Microbiol.9,2125–2136.

Rhee,K.J.,Wu,S.,Wu,X.,Huso,

D.L.,Karim, B.,Franco, A. A.,

Rabizadeh,S.,Golub,J.E.,Mathews,

L.E.,Shin,J.,Sartor,R.B.,Golen-

bock,D.,Hamad,A.R.,Gan,C.M.,

Housseau,F.,and Sears,C.L.(2009).

Induction of persistent colitis by a

human commensal,enterotoxigenic

Bacteroides fragilis,in wild-type

C57BL/6mice.Infect.Immun.77,

1708–1718.

Rosenfeldt,V.,Benfeldt,E.,Nielsen,S.

D.,Michaelsen,K.F.,Jeppesen,D.

L.,Valerius,N.H.,and Paerregaard,

A.(2003).Effect of probiotic Lac-

tobacillus strains in children with atopic dermatitis.J.Allergy Clin.

Immunol.111,389–395.

Round,J.L.,Lee,S.M.,Li,J.,Tran,

G.,Jabri, B.,Chatila,T. A.,and

Mazmanian,S.K.(2011).The Toll-like receptor2pathway establishes colonization by a commensal of the human microbiota.Science332, 974–977.

Round,J.L.,and Mazmanian,S.K.

(2009).The gut microbiota shapes intestinal immune responses dur-ing health and disease.Nat.Rev.

Immunol.9,313–323. Rowland,I.R.,Rumney,C.J.,Coutts, J.T.,and Lievense,L.C.(1998).

Effect of Bi?dobacterium longum and inulin on gut bacterial metab-olism and carcinogen-induced aber-rant crypt foci in rats.Carcinogenesis 19,281–285.

Sanderson,J.D.,and Hermon-Taylor,J.

(1992).Mycobacterial diseases of the gut:some impact from molecular biology.Gut33,145–147. Sfanos,K.S.,Bruno,T.C.,Maris,C.

H.,Xu,L.,Thoburn,C.J.,Demarzo,

A.M.,Meeker,A.K.,Isaacs,W.

B.,

and Drake,C.G.(2008).Pheno-typic analysis of prostate-in?ltrating lymphocytes reveals TH17and Treg skewing.Clin.Cancer Res.14, 3254–3261.

Silva,W.A.Jr.,Covas,D.T.,Panepucci, R.A.,Proto-Siqueira,R.,Siu?,J.L., Zanette,D.L.,Santos,A.R.,and Zago,M.A.(2003).The pro?le of gene expression of human marrow mesenchymal stem cells.Stem Cells 21,661–669.

Snel,J.,Heinen,P.P.,Blok,H.J.,Car-man,R.J.,Duncan,A.J.,Allen,P.

C.,and Collins,M.

D.(1995).Com-

parison of16S rRNA sequences of segmented?lamentous bacteria iso-lated from mice,rats,and chick-ens and proposal of“Candidatus arthromitus.”Int.J.Syst.Bacteriol.

45,780–782.

So,J.S.,Kwon,H.K.,Lee,C.G.,Yi,H.

J.,Park,J.A.,Lim,S.Y.,Hwang,K.

C.,Jeon,Y.H.,and Im,S.H.(2008).

Lactobacillus casei suppresses experi-mental arthritis by down-regulating T helper1effector functions.Mol.

Immunol.45,2690–2699.

Sokol,H.,Pigneur,B.,Watterlot,L., Lakhdari,O.,Bermudez-Humaran, L.G.,Gratadoux,J.J.,Blugeon,S., Bridonneau,C.,Furet,J.P.,Cor-thier,G.,Grangette,C.,Vasquez,N., Pochart,P.,Trugnan,G.,Thomas,G., Blottiere,H.M.,Dore,J.,Marteau, P.,Seksik,P.,and Langella,P.(2008).

Faecalibacterium prausnitzii is an

anti-in?ammatory commensal bac-

terium identi?ed by gut microbiota

analysis of Crohn disease patients.

Proc.Natl.Acad.Sci.U.S.A.105,

16731–16736.

Sokol,H.,Seksik,P.,Furet,J.P.,Firmesse,

O.,Nion-Larmurier,I.,Beaugerie,L.,

Cosnes,J.,Corthier,G.,Marteau,P.,

and Dore,J.(2009).Low counts of

Faecalibacterium prausnitzii in coli-

tis microbiota.In?amm.Bowel Dis.

15,1183–1189.

Sood,A.,Midha,V.,Makharia,G.K.,

Ahuja,V.,Singal,D.,Goswami,P.,

and Tandon,R.K.(2009).The pro-

biotic preparation,VSL#3induces

remission in patients with mild-

to-moderately active ulcerative col-

itis.Clin.Gastroenterol.Hepatol.7,

1202–1209,1209e1201.

Stepankova,R.,Powrie,F.,Kofronova,

O.,Kozakova,H.,Hudcovic,T.,

Hrncir,T.,Uhlig,H.,Read,S.,

Rehakova,Z.,Benada,O.,Heczko,P.,

Strus,M.,Bland,P.,and Tlaskalova-

Hogenova,H.(2007).Segmented

?lamentous bacteria in a de?ned

bacterial cocktail induce intestinal

in?ammation in SCID mice recon-

stituted with CD45RBhigh CD4+

T cells.In?amm.Bowel Dis.13,

1202–1211.

Stone,M.,Fortin,P.R.,Pacheco-

Tena,C.,and Inman,R.D.(2003).

Should tetracycline treatment be

used more extensively for rheuma-

toid arthritis?Metaanalysis demon-

strates clinical bene?t with reduc-

tion in disease activity.J.Rheumatol.

30,2112–2122.

Talham,G.L.,Jiang,H.Q.,Bos,N.

A.,and Cebra,J.J.(1999).Seg-

mented?lamentous bacteria are

potent stimuli of a physiologically

normal state of the murine gut

mucosal immune system.Infect.

Immun.67,1992–2000.

Toivanen,P.(2003).Normal intesti-

nal microbiota in the aetiopatho-

genesis of rheumatoid arthritis.Ann.

Rheum.Dis.62,807–811.

Turnbaugh,P.J.,Ridaura,V.K.,Faith,

J.J.,Rey,F.E.,Knight,R.,and Gor-

don,J.I.(2009).The effect of diet

on the human gut microbiome:a

metagenomic analysis in humanized

gnotobiotic mice.Sci.Transl.Med.1,

6ra14.

Tursi,A.,Brandimarte,G.,Papa,A.,

Giglio,A.,Elisei,W.,Giorgetti,G.M.,

Forti,G.,Morini,S.,Hassan,C.,Pis-

toia,M.A.,Modeo,M.E.,Rodino,

S.,D’Amico,T.,Sebkova,L.,Sacca,

N.,Di Giulio,E.,Luzza,F.,Imeneo,

M.,Larussa,T.,Di Rosa,S.,Annese,

V.,Danese,S.,and Gasbarrini,A.

(2010).Treatment of relapsing mild-

to-moderate ulcerative colitis with

the probiotic VSL#3as adjunc-

tive to a standard pharmaceutical

treatment:a double-blind,random-

ized,placebo-controlled study.Am.

J.Gastroenterol.105,2218–2227.

Umesaki,Y.,Okada,Y.,Matsumoto,

S.,Imaoka,A.,and Setoyama,H.

(1995).Segmented?lamentous bac-

teria are indigenous intestinal bacte-

ria that activate intraepithelial lym-

phocytes and induce MHC class II

molecules and fucosyl asialo GM1

glycolipids on the small intesti-

nal epithelial cells in the ex-germ-

free mouse.Microbiol.Immunol.39,

555–562.

Uronis,J.M.,Muhlbauer,M.,Herfarth,

H.H.,Rubinas,T.C.,Jones,G.S.,

and Jobin,C.(2009).Modulation

of the intestinal microbiota alters

colitis-associated colorectal cancer

susceptibility.PLoS ONE4,e6026.

doi:10.1371/journal.pone.0006026

Vaahtovuo,J.,Munukka,E.,Korkea-

maki,M.,Luukkainen,R.,and Toiva-

nen,P.(2008).Fecal microbiota

in early rheumatoid arthritis.J.

Rheumatol.35,1500–1505.

Veiga,P.,Gallini, C. A.,Beal, C.,

Michaud,M.,Delaney,M.L.,

Dubois,A.,Khlebnikov,A.,Van Hyl-

ckama Vlieg,J.E.,Punit,S.,Glick-

man,J.N.,Onderdonk,A.,Glim-

cher,L.H.,and Garrett,W.S.(2010).

Bi?dobacterium animalis https://www.sodocs.net/doc/0a15105227.html,c-

tis fermented milk product reduces

in?ammation by altering a niche

for colitogenic microbes.Proc.Natl.

Acad.Sci.U.S.A.107,18132–18137.

Viljanen,M.,Savilahti,E.,Haahtela,T.,

Juntunen-Backman,K.,Korpela,R.,

Poussa,T.,Tuure,T.,and Kuitunen,

M.(2005).Probiotics in the treat-

ment of atopic eczema/dermatitis

syndrome in infants:a double-blind

placebo-controlled trial.Allergy60,

494–500.

Vliagoftis,H.,Kouranos,V.D.,Betsi,G.

I.,and Falagas,M.E.(2008).Pro-

biotics for the treatment of aller-

gic rhinitis and asthma:systematic

review of randomized controlled tri-

als.Ann.Allergy Asthma Immunol.

101,570–579.

Ward,J.M.,Anver,M.R.,Haines,D.C.,

Melhorn,J.M.,Gorelick,P.,Yan,L.,

and Fox,J.G.(1996).In?ammatory

large bowel disease in immunode-

?cient mice naturally infected with

Helicobacter https://www.sodocs.net/doc/0a15105227.html,b.Anim.

Sci.46,15–20.

Wen,L.,Ley,R. E.,Volchkov,P.Y.,

Stranges,P.B.,Avanesyan,L.,Stone-

braker, A. C.,Hu, C.,Wong, F.

S.,Szot,G.L.,Bluestone,J. A.,

Gordon,J.I.,and Chervonsky,A.

V.(2008).Innate immunity and

intestinal microbiota in the develop-

ment of type1diabetes.Nature455,

1109–1113.

Wu,H.J.,Ivanov,Ii,Darce,J.,Hattori,

K.,Shima,T.,Umesaki,Y.,Littman,

D.R.,Benoist,C.,and Mathis,D.

(2010).Gut-residing segmented?la-

mentous bacteria drive autoimmune

arthritis via T helper17cells.Immu-

nity32,815–827.

Wu,S.,Rhee,K.J.,Albesiano, E.,

Rabizadeh,S.,Wu,X.,Yen,H.R.,

Huso,D.L.,Brancati,F.L.,Wick,

E.,Mcallister,

F.,Housseau,F.,Par-

doll,D.M.,and Sears,C.L.(2009).

A human colonic commensal pro-

motes colon tumorigenesis via acti-

vation of T helper type17T cell

responses.Nat.Med.15,1016–1022.

Yao,Z.,Fanslow,W. C.,Seldin,M.

F.,Rousseau,A.M.,Painter,S.L.,

Comeau,M.R.,Cohen,J.I.,and

Spriggs,M.K.(1995).Herpesvirus

Saimiri encodes a new cytokine,IL-

17,which binds to a novel cytokine

receptor.Immunity3,811–821.

Y oshioka,H.,Iseki,K.,and Fujita,K.

(1983).Development and differ-

ences of intestinal?ora in the neona-

tal period in breast-fed and bottle-

fed infants.Pediatrics72,317–321.

Zandman-Goddard,G.,and Shoen-

feld,Y.(2005).Infections and SLE.

Autoimmunity38,473–485.

Zhang,B.,Rong,G.,Wei,H.,Zhang,M.,

Bi,J.,Ma,L.,Xue,X.,Wei,G.,Liu,

X.,and Fang,G.(2008).The preva-

lence of Th17cells in patients with

gastric cancer.Biochem.Biophys.Res.

Commun.374,533–537.

Zhang,L.L.,Chen,X.,Zheng,P.Y.,Luo,

Y.,Lu,G.F.,Liu,Z.Q.,Huang,H.,

and Yang,P.C.(2010).Oral Bi?-

dobacterium modulates intestinal

immune in?ammation in mice with

food allergy.J.Gastroenterol.Hepa-

tol.25,928–934.

Con?ict of Interest Statement:The

authors declare that the research was

conducted in the absence of any

commercial or?nancial relationships

that could be construed as a potential

con?ict of interest.

Received:06May2011;accepted:16

August2011;published online:05Sep-

tember2011.

Citation:Kosiewicz MM,Zirnheld AL

and Alard P(2011)Gut microbiota,

immunity,and disease:a complex rela-

tionship.Front.Microbio.2:180.doi:

10.3389/fmicb.2011.00180

This article was submitted to Frontiers

in Cellular and Infection Microbiology,a

specialty of Frontiers in Microbiology.

Copyright?2011Kosiewicz,Zirnheld

and Alard.This is an open-access arti-

cle subject to a non-exclusive license

between the authors and Frontiers Media

SA,which permits use,distribution and

reproduction in other forums,provided

the original authors and source are cred-

ited and other Frontiers conditions are

complied with.

相关主题